Linked e-resources
Details
Table of Contents
Part I. Epidemiology of Polycystic Ovary Syndrome
1. Diagnostic Criteria and Epidemiology of PCOS
2. Prevalence, Presentation, and Diagnosis of PCOS in Adolescents
3. Polycystic Ovarian Syndrome: A Diagnosis of Exclusion
Part II. Pathophysiology, Endocrine and Metabolic Milieus of Polycystic Ovary Syndrome
4. Recent Advances in the Genetics of Polycystic Ovary Syndrome
5. The Hypothalamo-Pituitary Axis in PCOS
6. Ovarian Dysfunction in Polycystic Ovary Syndrome (PCOS)
7. The Role of the Adrenal Glands in the Hyperandrogenism associated with the Polycystic Ovarian Syndrome
8. Insulin Resistance and Lipotoxicity in PCOS: Causes and Consequences
9. Obesity, Dysmetabolic and Proinflammatory Milieu of Polycystic Ovary Syndrome
Part III. Management of Polycystic Ovary Syndrome
10. Managing PCOS in the Adolescent
11. Managing the PCOS-Related Symptoms of Hirsutism, Acne, and Female Pattern Hair Loss
12. Role of Insulin-Sensitizing Drugs in PCOS Management
13. Role of Statins & Resveratrol in PCOS Management
14. Role of Lifestyle, Diet and Exercise in the Management of Polycystic Ovarian Syndrome
Part IV. Management of Polycytic Ovary Syndrome Related Infertility
15. Managing PCOS-Related Infertility: Ovulation Induction, In Vitro Fertilization, and In Vitro Maturation
16. Considerations and Challenges for Pregnancy in Polycystic Ovary Syndrome
Part V. The Role of Surgery in the Management of Polycystic Ovary Syndrome
17. Rationale and considerations for Bariatric Surgery
18. Surgical Management of Polycystic Ovary Syndrome: A Contemporary Viewpoint on Place of Ovarian Surgery in PCOS Management
Part VI. Health Risks and Burden of Polycystic Ovary Syndrome
19. PCOS and its Association with Mental Health
20. Obstructive Sleep Apnea in Polycystic Ovary Syndrome
21. Endometrial cancer and pre-cancer in polycystic ovary syndrome
22. Economic Burden of Polycystic Ovary Syndrome
Part VII. Emerging Concepts in Polycystic Ovary Syndrome
23. The Role of Angiogenic Factor Dysregulation in the Pathogenesis of Polycystic Ovarian Syndrome
24. Emerging Concepts: Role of Vitamin D Deficiency in the Pathogenesis of PCOS
25. Anti-Mullerian Hormone Signaling relevance for pathophysiology of PCOS & implications for novel therapeutic approaches to managing ovulatory dysfunction of PCOS
26. Newer Glucose Lowering Medications and Potential Role in Metabolic Management of PCOS
27. Intergenerational Implications of PCOS.
1. Diagnostic Criteria and Epidemiology of PCOS
2. Prevalence, Presentation, and Diagnosis of PCOS in Adolescents
3. Polycystic Ovarian Syndrome: A Diagnosis of Exclusion
Part II. Pathophysiology, Endocrine and Metabolic Milieus of Polycystic Ovary Syndrome
4. Recent Advances in the Genetics of Polycystic Ovary Syndrome
5. The Hypothalamo-Pituitary Axis in PCOS
6. Ovarian Dysfunction in Polycystic Ovary Syndrome (PCOS)
7. The Role of the Adrenal Glands in the Hyperandrogenism associated with the Polycystic Ovarian Syndrome
8. Insulin Resistance and Lipotoxicity in PCOS: Causes and Consequences
9. Obesity, Dysmetabolic and Proinflammatory Milieu of Polycystic Ovary Syndrome
Part III. Management of Polycystic Ovary Syndrome
10. Managing PCOS in the Adolescent
11. Managing the PCOS-Related Symptoms of Hirsutism, Acne, and Female Pattern Hair Loss
12. Role of Insulin-Sensitizing Drugs in PCOS Management
13. Role of Statins & Resveratrol in PCOS Management
14. Role of Lifestyle, Diet and Exercise in the Management of Polycystic Ovarian Syndrome
Part IV. Management of Polycytic Ovary Syndrome Related Infertility
15. Managing PCOS-Related Infertility: Ovulation Induction, In Vitro Fertilization, and In Vitro Maturation
16. Considerations and Challenges for Pregnancy in Polycystic Ovary Syndrome
Part V. The Role of Surgery in the Management of Polycystic Ovary Syndrome
17. Rationale and considerations for Bariatric Surgery
18. Surgical Management of Polycystic Ovary Syndrome: A Contemporary Viewpoint on Place of Ovarian Surgery in PCOS Management
Part VI. Health Risks and Burden of Polycystic Ovary Syndrome
19. PCOS and its Association with Mental Health
20. Obstructive Sleep Apnea in Polycystic Ovary Syndrome
21. Endometrial cancer and pre-cancer in polycystic ovary syndrome
22. Economic Burden of Polycystic Ovary Syndrome
Part VII. Emerging Concepts in Polycystic Ovary Syndrome
23. The Role of Angiogenic Factor Dysregulation in the Pathogenesis of Polycystic Ovarian Syndrome
24. Emerging Concepts: Role of Vitamin D Deficiency in the Pathogenesis of PCOS
25. Anti-Mullerian Hormone Signaling relevance for pathophysiology of PCOS & implications for novel therapeutic approaches to managing ovulatory dysfunction of PCOS
26. Newer Glucose Lowering Medications and Potential Role in Metabolic Management of PCOS
27. Intergenerational Implications of PCOS.